Shares of GSK PLC GSK rose 1.79% to £14.47 Thursday, on what proved to be an all-around rough trading session for the stock ...
Corporate-giving strategists share what works in closing the deal on grants and other valuable types of support from ...
Britain's benchmark index extended declines on Thursday as top healthcare stocks continued to decline on fears of higher U.S.
3don MSN
Enhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new ...
GlaxoSmithKline Pharmaceuticals reported a significant increase in net profit to Rs 229 crore for the third quarter ending ...
Agencies have always strived to build trust with their pharma clients, but that task is becoming more arduous as AI takes center stage.
Kenvue's improvements in marketing and management could drive future growth. Read why there is potential for a turnaround for ...
The lawsuit filed in Maricopa County Superior Court contends GlaxoSmithKline's actions violate the Arizona Consumer Fraud Act ...
The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...
GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results